The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNF[alpha]- and FasL-induced apoptosis by interacting with caspase-8

• Published in: Apoptosis (London) 2011-03, Vol.16 (3), p.256
• Main Authors: Dufour, Florent, Sasseville, A Marie-josée, Chabaud, Stéphane, Massie, Bernard, Siegel, Richard M, Langelier, Yves
• Format: Article
• Language: English
• ISSN: 1360-8185; 1573-675X
• DOI: 10.1007/s10495-010-0560-2

We previously reported that HSV-2 R1, the R1 subunit (ICP10; UL39) of herpes simplex virus type-2 ribonucleotide reductase, protects cells against apoptosis induced by the death receptor (DR) ligands tumor necrosis factor-alpha- (TNFα) and Fas ligand (FasL) by interrupting DR-mediated signaling at, or upstream of, caspase-8 activation. Further investigation of the molecular mechanism underlying HSV-2 R1 protection showed that extracellular-regulated kinase 1/2 (ERK1/2), phosphatidylinositol 3-kinase (PI3-K)/Akt, NF-κB and JNK survival pathways do not play a major role in this antiapoptotic function. Interaction studies revealed that HSV-2 R1 interacted constitutively with caspase-8. The HSV-2 R1 deletion mutant R1(1-834)-GFP and Epstein-Barr virus (EBV) R1, which did not protect against apoptosis induced by DR ligands, did not interact with caspase-8, indicating that interaction is required for protection. HSV-2 R1 impaired caspase-8 activation induced by caspase-8 over-expression, suggesting that interaction between the two proteins prevents caspase-8 dimerization/activation. HSV-2 R1 bound to caspase-8 directly through its prodomain but did not interact with either its caspase domain or Fas-associated death domain protein (FADD). Interaction between HSV-2 R1 and caspase-8 disrupted FADD-caspase-8 binding. We further demonstrated that individually expressed HSV-1 R1 (ICP6) shares, with HSV-2 R1, the ability to bind caspase-8 and to protect cells against DR-induced apoptosis. Finally, as the long-lived Fas protein remained stable during the early period of infection, experiments with the HSV-1 UL39 deletion mutant ICP6[increment] showed that HSV-1 R1 could be essential for the protection of HSV-1-infected cells against FasL.[PUBLICATION ABSTRACT]